These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 13233573)

  • 21. Effects of aldosterone (electrocortin), 9-alpha-fluorohydrocortisone acetate, and 1-dehydrocortisone (metacortandracin) in rheumatoid arthritis.
    WARD LE; HENCH PS
    Ann N Y Acad Sci; 1955 May; 61(2):620-35. PubMed ID: 13249285
    [No Abstract]   [Full Text] [Related]  

  • 22. The acute renal effects of 9-alpha fluorohydrocortisone in human subjects with intact adrenals.
    HUFFMAN ER; WILSON GM; CLARK GM; SMYTH CJ
    J Lab Clin Med; 1956 May; 47(5):747-51. PubMed ID: 13319883
    [No Abstract]   [Full Text] [Related]  

  • 23. Studies on the percutaneous absorption of fludrocortisone.
    LIVINGOOD CS; HILDEBRAND JF; KEY JS; SMITH RW
    AMA Arch Derm; 1955 Oct; 72(4):313-27. PubMed ID: 13257907
    [No Abstract]   [Full Text] [Related]  

  • 24. The effect of topically applied compound F in selected dermatoses.
    SULZBERGER MB; WITTEN VH
    J Invest Dermatol; 1952 Aug; 19(2):101-2. PubMed ID: 14955641
    [No Abstract]   [Full Text] [Related]  

  • 25. Clinical evaluation of topical fludrocortisone.
    VAN DE ERVE J
    AMA Arch Derm; 1956 Jul; 74(1):92-4. PubMed ID: 13325969
    [No Abstract]   [Full Text] [Related]  

  • 26. The comparative effects of metacortandracin, 9-alpha-fluorohydrocortisone and hydrocortisone upon ACTH secretion in man.
    KUPPERMAN HS; BLATT MH; VESELL M; GAGLIANI J; WEISBADER H; VOSBURGH L
    J Clin Endocrinol Metab; 1955 Aug; 15(8):911-22. PubMed ID: 13242644
    [No Abstract]   [Full Text] [Related]  

  • 27. The effects of aldosterone (electrocortin) and of 9alpha-fluorohydrocortisone acetate on rheumatoid arthritis: preliminary report.
    WARD LE; POLLEY HF; SLOCUMB CH; HENCH PS; MASON HL; MATTOX VR; POWER MH
    Proc Staff Meet Mayo Clin; 1954 Dec; 29(26):649-63. PubMed ID: 13224745
    [No Abstract]   [Full Text] [Related]  

  • 28. Suppression of uterine growth by purified hydrocortisone acetate, 9alpha-fluorohydrocortisone acetate and corticotropin.
    VELARDO JT; STURGIS SH
    J Clin Endocrinol Metab; 1956 Apr; 16(4):496-506. PubMed ID: 13306767
    [No Abstract]   [Full Text] [Related]  

  • 29. Anti-inflammatory activity of delta1-9alpha-fluorohydrocortisone acetate.
    DULIN WE
    Proc Soc Exp Biol Med; 1955 Oct; 90(1):115-7. PubMed ID: 13273371
    [No Abstract]   [Full Text] [Related]  

  • 30. Influence of 9-alpha fluorohydrocortisone on contractility and Na content of isolated cat papillary muscle.
    TANZ RD; CLARK GM; WHITEHEAD RW
    Proc Soc Exp Biol Med; 1956 May; 92(1):167-9. PubMed ID: 13336108
    [No Abstract]   [Full Text] [Related]  

  • 31. [Water and sodium chloride test in adrenalectomized dogs treated with cortexon, aldosterone and 9 alpha-fluorohydrocortisone].
    DETTBARN W; GROSS F
    Schweiz Med Wochenschr; 1955 Jul; 85(27):662-3. PubMed ID: 13246602
    [No Abstract]   [Full Text] [Related]  

  • 32. Hydrocortisone (compound F) acetate ointment in dermatological therapy.
    SULZBERGER MB; WITTEN VH; SMITH CC
    J Am Med Assoc; 1953 Feb; 151(6):468-72. PubMed ID: 13011029
    [No Abstract]   [Full Text] [Related]  

  • 33. Use of a new corticosteroid (aristocort diacetate) in dermatology.
    REIN CR; FLEISCHMAJER R; ROSENTHAL AL
    J Am Med Assoc; 1957 Dec; 165(14):1821-3. PubMed ID: 13480831
    [No Abstract]   [Full Text] [Related]  

  • 34. [Hydrocortisone ointment and hydrocortisone-terramycin ointment in the treatment of dermatitis].
    SCHLOCKERMANN FW
    Ther Ggw; 1955 Sep; 94(9):331-3. PubMed ID: 13291268
    [No Abstract]   [Full Text] [Related]  

  • 35. Clinical use of fludrocortisone acetate; preliminary report.
    HAMWI GJ; GOLDBERG RF
    J Am Med Assoc; 1955 Dec; 159(17):1598-601. PubMed ID: 13271122
    [No Abstract]   [Full Text] [Related]  

  • 36. Comparative effectiveness of fluorohydrocortisone and hydrocortisone in the topical treatment of skin diseases.
    SULZBERGER MB
    Ann N Y Acad Sci; 1955 May; 61(2):599-604. PubMed ID: 13249282
    [No Abstract]   [Full Text] [Related]  

  • 37. On the adrenal cortical steroids in relation to allergic dermatoses.
    SULZBERGER MB
    N Y State J Med; 1956 Jun; 56(11):1827-31. PubMed ID: 13322280
    [No Abstract]   [Full Text] [Related]  

  • 38. Sodium retention and edema from percutaneous absorption of fludrocortisone acetate.
    FITZPATRICK TB; GRISWOLD HC; HICKS JH
    J Am Med Assoc; 1955 Jul; 158(13):1149-52. PubMed ID: 14392056
    [No Abstract]   [Full Text] [Related]  

  • 39. [9alpha-Fluorohydrocortisone in local dermatological application].
    HEWITT J; RICHON P; MEYER JJ; DESVIGNES P
    Bull Soc Fr Dermatol Syphiligr; 1956; (2):140-2. PubMed ID: 13342788
    [No Abstract]   [Full Text] [Related]  

  • 40. The use of 9-alpha-fluorohydrocortisone in the therapy of dermatoses.
    ROBINSON HM; ROBINSON RC; COHEN MM
    Bull Sch Med Univ Md; 1955 Jul; 40(3):72-5. PubMed ID: 14389899
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.